Endothelial PHD2 deficiency induces nitrative stress suppression of caveolin-1 in pulmonary hypertension
Author
Liu, BinPeng, Yi
Yi, Dan
Machireddy, Narsa
Dong, Daoyin
Ramirez, Karina
Dai, Jingbo
Vanderpool, Rebecca
Zhu, Maggie M
Dai, Zhiyu
Zhao, You-Yang
Affiliation
Division of Pulmonary, Critical Care and Sleep, Dept of Internal Medicine, University of ArizonaCollege of Medicine-Phoenix, University of Arizona
Issue Date
2022-12-22
Metadata
Show full item recordPublisher
European Respiratory SocietyCitation
Liu, B., Peng, Y., Yi, D., Machireddy, N., Dong, D., Ramirez, K., Dai, J., Vanderpool, R., Zhu, M. M., Dai, Z., & Zhao, Y.-Y. (2022). Endothelial PHD2 deficiency induces nitrative stress via suppression of caveolin-1 in pulmonary hypertension. The European Respiratory Journal, 60(6).Journal
European Respiratory JournalRights
Copyright ©The authors 2022. This version is distributed under the terms of the Creative Commons Attribution NonCommercial Licence 4.0.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Our recently identified novel mouse model (Egln1Tie2Cre, Egln1 encoding prolyl hydroxylase 2 (PHD2)) has obliterative vascular remodelling and right heart failure, making it an excellent model to use in this study to examine the role of nitrative stress in obliterative vascular remodelling.Note
Open access articleEISSN
1399-3003PubMed ID
35798360Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1183/13993003.02643-2021
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright ©The authors 2022. This version is distributed under the terms of the Creative Commons Attribution NonCommercial Licence 4.0.
Related articles
- Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.
- Authors: Dai Z, Li M, Wharton J, Zhu MM, Zhao YY
- Issue date: 2016 Jun 14
- Egln1(Tie2Cre) Mice Exhibit Similar Therapeutic Responses to Sildenafil, Ambrisentan, and Treprostinil as Pulmonary Arterial Hypertension (PAH) Patients, Supporting Egln1(Tie2Cre) Mice as a Useful PAH Model.
- Authors: Peng Y, Dai J, Zhao YY
- Issue date: 2023 Jan 25
- Endothelial Autocrine Signaling through CXCL12/CXCR4/FoxM1 Axis Contributes to Severe Pulmonary Arterial Hypertension.
- Authors: Yi D, Liu B, Wang T, Liao Q, Zhu MM, Zhao YY, Dai Z
- Issue date: 2021 Mar 20
- Loss of Endothelial Hypoxia Inducible Factor-Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis.
- Authors: Dai Z, Cheng J, Liu B, Yi D, Feng A, Wang T, An L, Gao C, Wang Y, Zhu MM, Zhang X, Zhao YY
- Issue date: 2021 Nov 16
- Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.
- Authors: Tang H, Babicheva A, McDermott KM, Gu Y, Ayon RJ, Song S, Wang Z, Gupta A, Zhou T, Sun X, Dash S, Wang Z, Balistrieri A, Zheng Q, Cordery AG, Desai AA, Rischard F, Khalpey Z, Wang J, Black SM, Garcia JGN, Makino A, Yuan JX
- Issue date: 2018 Feb 1